The Food and Drug Administration said it will continue to regulate hemp products that contain "cannabis or cannabis-derived compounds" despite President Trump legalizing the production and marketing of industrial hemp under the farm bill signed Thursday.
The big picture: The hemp-derived and non-psychoactive compound cannabidiol, or CBD oil, has previously been approved by the FDA for the treatment of two forms of epilepsy. But its increasing popularity as an ingredient in lotions, dietary supplements and other medicinal applications has thrust it into murky legal territory, with the FDA ruling that, like any illegal substance, it will remain subject to regulation.
